The Washington State University College of Pharmacy and Pharmaceutical Sciences is one of two PharmD granting institutions within the state of Washington.

During the past decade, Washington State University College of Pharmacy and Pharmaceutical Sciences conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington State University College of Pharmacy and Pharmaceutical Sciences" #1 collaborator was "National Center for Complementary and Integrative Health (NCCIH)" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Washington State University College of Pharmacy and Pharmaceutical Sciences" are "Interaction Drug Food" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Endogenous Biomarkers" (1 trials), "Interaction" (1 trials) and "Interaction, Adverse Herb-Drug" (1 trials). Many other conditions were trialed in "Washington State University College of Pharmacy and Pharmaceutical Sciences" in a lesser frequency.

Most popular intervention types in "Washington State University College of Pharmacy and Pharmaceutical Sciences" are "Drug" (4 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cimetidine 400 MG" (1 trials), "Cinnamon (2 g)" (1 trials), "Dextromethorphan HBr" (1 trials), "Furosemide Oral Liquid Product" (1 trials) and "Goldenseal (Hydrastis canadensis)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington State University College of Pharmacy and Pharmaceutical Sciences" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Washington State University College of Pharmacy and Pharmaceutical Sciences". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Washington State University College of Pharmacy and Pharmaceutical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Washington State University College of Pharmacy and Pharmaceutical Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".